Getting It Done
to Improve Lives

Our team combines deep science expertise with an entrepreneurial “get it done” mindset. Beginning with our early discovery work through our late-stage pivotal trials, we focus on driving the best ideas forward. With our know-how, passion, and sense of urgency, we work every day toward a single goal: to improve the lives of patients across the globe.

Get to Know Our Team

Alice McElhinney

Director of Strategic Operations

Allison Vavala, M.B.A.

Director, CMC Portfolio Management

Brian Boyce, M.B.A.

Brian Hubbard, Ph.D.

Chief Executive Officer

Chloe Kamps, M.A.

Translational Program Manager

Dan Meyers, M.D.

Chief Medical Officer

Doug Daniels, Ph.D.

Head of Biologics

Chief Development Officer

Julianne Averill, M.S.

Chief Financial Officer

Kristen Richardson

Chief People and Performance Officer

Operations Manager

Mark Young, J.D.

General Counsel

Matthias Ocker, M.D.

Vice President of Translational Medicine

May Li, M.D., M.S.

Head of Clinical Operations

Mike Serrano-Wu, Ph.D.

Chief Scientific Officer

Ming Yang, M.S.

Medical Director

Sandy Hurd, Ph.D.

Shary Lavoie, M.A.

Clinical Operations Director

People Operations Specialist

Tammy Pasqualini

Clinical Program Director

Ulrike Rauh, Ph.D.

Vice President of Oncology

Virendar Kaushik, Ph.D.

Head of Research

Yiwei Zong, Ph.D.

Chief Operating Officer

Our Board of Directors

Brian Hubbard, Ph.D.

CEO, Anji Pharmaceuticals

Yiwei Zong, Ph.D.

COO, Anji Pharmaceuticals

Jun Mao, Ph.D.

Founder, JMCR Partners

Jason Wu

Partner, Fenghe Group

Lin Sun

Founding Partner, CR Capital

For partnerships, investment opportunities, or to learn more about our work, contact us.